Healthcare & Life Sciences

NeokenBio

South Koreawww.neocannbio.com/

NeokenBio is a Healthcare & Life Sciences startup based in South Korea, most recent round Series B, 1 tracked investor.

Activeseries-b

View Full Profile Website

series-b

Stage

Investors

About NeokenBio

NeokenBio is a company headquartered in South Korea. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.

NeokenBio develops cannabinoid-based drugs derived from hemp, focusing on treatments for intractable and brain diseases such as epilepsy, using patented processing technologies and metabolic engineering for scalable production.

Explore NeokenBio's full profile on Brouky

Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.

View Startup Profile →View pricing

Other Startups in South Korea

All startups →

NeogenTCseries-b Neofect NeoAI Cloudseed Neardocseed NdotLightseries-a N.CERseries-a NeoLAB Convergenceseries-b Neosapienceseries-b Neubilityseries-b Neuracle Geneticsseries-c-plus 뉴로퓨전 / Neurofusion Neurophetseries-a